Discovering The Potential Therapeutic Benefits of IGHV3-6 (G28453)

Target Name: IGHV3-6

NCBI ID: G28453

IGHV3-6

Other Name(s): 3-06P | Immunoglobulin heavy variable 3-6 (pseudogene) | IGHV36 | immunoglobulin heavy variable 3-6 (pseudogene)

Discovering The Potential Therapeutic Benefits of IGHV3-6

IGHV3-6 (3-06P) is a glycoprotein which is expressed in various tissues of the body, including the liver, spleen, and Peyer's patches of the small intestine. It is a type of transmembrane protein which consists of a single transmembrane domain and a cytoplasmic tail.

IGHV3-6 is a member of the IGH family of proteins, which are involved in the immune response. The IGH family plays a crucial role in the development and maintenance of the immune system, as well as in regulating inflammation.

One of the unique features of IGHV3-6 is its cytoplasmic tail, which is composed of a series of glycans. The cytoplasmic tail of IGHV3-6 is involved in its ability to interact with other cells and molecules in the body, including viruses and bacteria.

IGHV3-6 has also been shown to play a role in the regulation of inflammation. In addition, IGHV3-6 has been shown to have neuroprotective properties, which may make it a potential drug target for various neurological disorders.

Despite its potential role in the immune system and neuroprotection, IGHV3-6 is not yet a well-established drug target. There is currently no approved drug that targets IGHV3-6, and research is being conducted to determine if IGHV3-6 can be used as a potential drug or biomarker in various diseases.

In addition to its potential drug target properties, IGHV3-6 also has potential as a biomarker for several diseases. For example, IGHV3-6 has been shown to be elevated in the blood of individuals with various diseases, including diabetes and cancer.

In addition to its potential drug and biomarker properties, IGHV3-6 is also of interest to researchers because of its unique structure and biology. Studies have shown that IGHV3-6 has a unique fold structure, which may make it a potential target for small molecules.

Overall, IGHV3-6 is a promising protein with potential as a drug target or biomarker. Further research is needed to determine its full role in the immune system and the body, and to develop new treatments based on its unique properties.

Protein Name: Immunoglobulin Heavy Variable 3-6 (pseudogene)

The "IGHV3-6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV3-6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets